Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (5108)
All Articles published online
|
Nov 14, 2010 (publication date) through Apr 26, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Salama H, Zekri ARN, Bahnassy AA, Medhat E, Halim HA, Ahmed OS, Mohamed G, Alim SAA, Sherif GM. Autologous CD34+ and CD133+ stem cells transplantation in patients with end stage liver disease. World J Gastroenterol 2010; 16(42): 5297-5305 [PMID: 21072892 DOI: 10.3748/wjg.v16.i42.5297] |
|---|---|
| URL: | https://www.wjgnet.com/1948-0210/full/v16/i42/5297.htm |
| Number | Citing Articles |
| 1 |
Ashish Kumar, Nirupama Trehan Pati, Shiv Kumar Sarin. Use of Stem Cells for Liver Diseases—Current Scenario. Journal of Clinical and Experimental Hepatology 2011; 1(1): 17 doi: 10.1016/S0973-6883(11)60114-X
|
| 2 |
Maria Giovanna Francipane, Melchiorre Cervello, Giovanni Battista Vizzini, Giada Pietrosi, Giuseppe Montalto. Management of Liver Failure: From Transplantation to Cell-Based Therapy. Cell Medicine 2011; 2(1): 9 doi: 10.3727/215517911X575993
|
| 3 |
John Langford, Gregory T. Tietjen. Stem Cell Therapy for Vascular Diseases. 2021; : 385 doi: 10.1007/978-3-030-56954-9_18
|
| 4 |
Caecilia H. C. Sukowati, Claudio Tiribelli. Cell Biology and Translational Medicine, Volume 17. Advances in Experimental Medicine and Biology 2022; 1401: 57 doi: 10.1007/5584_2022_719
|
| 5 |
Goshi Shiota, Noriko Itaba. Progress in stem cell‐based therapy for liver disease. Hepatology Research 2017; 47(2): 127 doi: 10.1111/hepr.12747
|
| 6 |
Zhihong Wan, Shaoli You, Yihui Rong, Bing Zhu, Aimin Zhang, Hong Zang, Long Xiao, Guoming Xie, Shaojie Xin. CD34+ Hematopoietic Stem Cells Mobilization, Paralleled with Multiple Cytokines Elevated in Patients with HBV-Related Acute-on-Chronic Liver Failure. Digestive Diseases and Sciences 2013; 58(2): 448 doi: 10.1007/s10620-012-2458-z
|
| 7 |
Ioannis Drosos, George Kolios. Stem Cells in Liver Regeneration and Their Potential Clinical Applications. Stem Cell Reviews and Reports 2013; 9(5): 668 doi: 10.1007/s12015-013-9437-4
|
| 8 |
Ahmer Irfan, Irfan Ahmed. Stem Cells: The Future of Personalised Medicine?. Medical Equipment Insights 2014; 5: MEI.S13177 doi: 10.4137/MEI.S13177
|
| 9 |
Abdel-Rahman N. Zekri, Hosny Salama, Eman Medhat, Sherief Musa, Hanan Abdel-Haleem, Ola S. Ahmed, Hanan Abdel Hafez Khedr, Mai M. Lotfy, Khaled S. Zachariah, Abeer A. Bahnassy. The impact of repeated autologous infusion of haematopoietic stem cells in patients with liver insufficiency. Stem Cell Research & Therapy 2015; 6(1) doi: 10.1186/s13287-015-0106-1
|
| 10 |
Xin-Hao Hu, Lan Chen, Hao Wu, Yang-Bo Tang, Qiu-Min Zheng, Xu-Yong Wei, Qiang Wei, Qi Huang, Jian Chen, Xiao Xu. Cell therapy in end-stage liver disease: replace and remodel. Stem Cell Research & Therapy 2023; 14(1) doi: 10.1186/s13287-023-03370-z
|
| 11 |
Xiao-lun Huang, Le Luo, Lan-yun Luo, Hua Xue, Ling-ling Wei, Yu-tong Yao, Hai-bo Zou, Xiao-bing Huang, Yi-fan Zhu, Tian Zhang, Ping Xie, Mao-zhu Yang, Shao-ping Deng. Clinical Outcome of Autologous Hematopoietic Stem Cell Infusion via Hepatic Artery or Portal Vein in Patients with End-stage Liver Diseases. Chinese Medical Sciences Journal 2014; 29(1): 15 doi: 10.1016/S1001-9294(14)60018-3
|
| 12 |
Toshihiko Matsumoto, Taro Takami, Isao Sakaida. Cell transplantation as a non-invasive strategy for treating liver fibrosis. Expert Review of Gastroenterology & Hepatology 2016; 10(5): 639 doi: 10.1586/17474124.2016.1134313
|
| 13 |
Benjamin J. Dwyer, Mark T. Macmillan, Paul N. Brennan, Stuart J. Forbes. Cell therapy for advanced liver diseases: Repair or rebuild. Journal of Hepatology 2021; 74(1): 185 doi: 10.1016/j.jhep.2020.09.014
|
| 14 |
Vishal Garg, Hitendra Garg, Arshi Khan, Nirupama Trehanpati, Ashish Kumar, Barjesh Chander Sharma, Puja Sakhuja, Shiv Kumar Sarin. Granulocyte Colony–Stimulating Factor Mobilizes CD34+ Cells and Improves Survival of Patients With Acute-on-Chronic Liver Failure. Gastroenterology 2012; 142(3): 505 doi: 10.1053/j.gastro.2011.11.027
|
| 15 |
Jong‐Woo Cho, Chul‐Young Lee, Yong Ko. Therapeutic potential of mesenchymal stem cells overexpressing human forkhead box A2 gene in the regeneration of damaged liver tissues. Journal of Gastroenterology and Hepatology 2012; 27(8): 1362 doi: 10.1111/j.1440-1746.2012.07137.x
|
| 16 |
Francesco Paolo Russo, Patrizia Burra, Maurizio Parola. Adult Stem Cells. Stem Cell Biology and Regenerative Medicine 2014; : 319 doi: 10.1007/978-1-4614-9569-7_13
|
| 17 |
J. K. Moore, B. M. Stutchfield, S. J. Forbes. Systematic review: the effects of autologous stem cell therapy for patients with liver disease. Alimentary Pharmacology & Therapeutics 2014; 39(7): 673 doi: 10.1111/apt.12645
|
| 18 |
Yantian Cao, Bangjie Zhang, Rong Lin, Qingzhi Wang, Jie Wang, Fangfang Shen. Mesenchymal Stem Cell Transplantation for Liver Cell Failure: A New Direction and Option. Gastroenterology Research and Practice 2018; 2018: 1 doi: 10.1155/2018/9231710
|
| 19 |
Hosny Salama, Abdel-Rahman N Zekri, Eman Medhat, Shereen A Al Alim, Ola S Ahmed, Abeer A Bahnassy, Mai M Lotfy, Rasha Ahmed, Sherief Musa. Peripheral vein infusion of autologous mesenchymal stem cells in Egyptian HCV-positive patients with end-stage liver disease. Stem Cell Research & Therapy 2014; 5(3) doi: 10.1186/scrt459
|
| 20 |
Ming-Fang Wang, You-Bing Li, Xiao-Juan Gao, Hao-Yang Zhang, Su Lin, Yue-Yong Zhu. Efficacy and safety of autologous stem cell transplantation for decompensated liver cirrhosis: A retrospective cohort study. World Journal of Stem Cells 2018; 10(10): 138-145 doi: 10.4252/wjsc.v10.i10.138
|
| 21 |
Francesco Paolo Russo, Debora Bizzaro. Textbook of Liver Transplantation. 2022; : 733 doi: 10.1007/978-3-030-82930-8_43
|
| 22 |
Pietro Andreone, Lucia Catani, Cristina Margini, Lucia Brodosi, Stefania Lorenzini, Daria Sollazzo, Benedetta Nicolini, Rosaria Giordano, Tiziana Montemurro, Simonetta Rizzi, Elisa Dan, Valeria Giudice, Mariele Viganò, Andrea Casadei, Francesco G. Foschi, Deborah Malvi, Mauro Bernardi, Fabio Conti, Roberto M. Lemoli. Reinfusion of highly purified CD133+ bone marrow-derived stem/progenitor cells in patients with end-stage liver disease: A phase I clinical trial. Digestive and Liver Disease 2015; 47(12): 1059 doi: 10.1016/j.dld.2015.08.018
|
| 23 |
Ahmer Irfan. Liver, Lung and Heart Regeneration. Stem Cells in Clinical Applications 2017; : 41 doi: 10.1007/978-3-319-46693-4_3
|
| 24 |
Ahmer Irfan, Irfan Ahmed. Could Stem Cell Therapy be the Cure in Liver Cirrhosis?. Journal of Clinical and Experimental Hepatology 2015; 5(2): 142 doi: 10.1016/j.jceh.2014.03.042
|
| 25 |
Meza-Ríos Alejandra, Armendáriz-Borunda Juan, Sandoval-Rodríguez Ana. Cell therapy for liver diseases: current medicine and future promises. Expert Review of Gastroenterology & Hepatology 2015; 9(6): 837 doi: 10.1586/17474124.2015.1016913
|
| 26 |
Jun Liang, Huayong Zhang, Cheng Zhao, Dandan Wang, Xiaolei Ma, Shengnan Zhao, Shiying Wang, Lingying Niu, Lingyun Sun. Effects of allogeneic mesenchymal stem cell transplantation in the treatment of liver cirrhosis caused by autoimmune diseases. International Journal of Rheumatic Diseases 2017; 20(9): 1219 doi: 10.1111/1756-185X.13015
|
| 27 |
Gehan El-Akabawy, Abeer El-Mehi. Mobilization of endogenous bone marrow-derived stem cells in a thioacetamide-induced mouse model of liver fibrosis. Tissue and Cell 2015; 47(3): 257 doi: 10.1016/j.tice.2015.03.003
|
| 28 |
Shao-Peng Zheng, Ao-Jian Deng, Jing-Jing Zhou, Ling-Zhi Yuan, Xiao Shi, Fen Wang. Endoscopic ultrasound-guided intraportal injection of autologous bone marrow in patients with decompensated liver cirrhosis: A case series. World Journal of Gastrointestinal Surgery 2023; 15(4): 655-663 doi: 10.4240/wjgs.v15.i4.655
Abstract(215) |
Core Tip(193) |
Full Article(HTML)(884)
|
Full Article (PDF)-1319K(80)
|
Full Article (Word)-492K(30)
|
Audio-883K(1)
|
Peer-Review Report-371K(25)
|
Answering Reviewers-98K(23)
|
Times Cited (0)
|
Total Visits (2522)
|
Open
|
| 29 |
Stuart J. Forbes, Philip N. Newsome. New horizons for stem cell therapy in liver disease. Journal of Hepatology 2012; 56(2): 496 doi: 10.1016/j.jhep.2011.06.022
|
| 30 |
Isao Sakaida. The current state of liver regeneration therapy. Kanzo 2016; 57(6): 269 doi: 10.2957/kanzo.57.269
|
| 31 |
Guang-Peng Zhou, Yi-Zhou Jiang, Li-Ying Sun, Zhi-Jun Zhu. Therapeutic effect and safety of stem cell therapy for chronic liver disease: a systematic review and meta-analysis of randomized controlled trials. Stem Cell Research & Therapy 2020; 11(1) doi: 10.1186/s13287-020-01935-w
|
| 32 |
Chuan-Xin Wu, Deng Wang, Ying Cai, Ao-Ran Luo, Hang Sun. Effect of Autologous Bone Marrow Stem Cell Therapy in Patients with Liver Cirrhosis: A Meta-analysis. Journal of Clinical and Translational Hepatology 2019; 7(X): 1 doi: 10.14218/JCTH.2019.00008
|
| 33 |
Lucia Giuli, Francesco Santopaolo, Maria Pallozzi, Antonio Pellegrino, Gaetano Coppola, Antonio Gasbarrini, Francesca Romana Ponziani. Cellular therapies in liver and pancreatic diseases. Digestive and Liver Disease 2023; 55(5): 563 doi: 10.1016/j.dld.2022.11.013
|
| 34 |
Ping Wang, Francesco Petrella, Luca Nicosia, Massimo Bellomi, Stefania Rizzo. Molecular Imaging of Stem Cell Transplantation for Liver Diseases: Monitoring, Clinical Translation, and Theranostics. Stem Cells International 2016; 2016: 1 doi: 10.1155/2016/4058656
|
| 35 |
James A. Thomas, Stuart J. Forbes. Regenerative Medicine and Cell Therapy. 2013; : 233 doi: 10.1007/978-1-62703-098-4_11
|
| 36 |
Muslimah Alsulami, Rewaida Abdel-Gaber. Cell therapy as a new approach on hepatic fibrosis of murine model of Schistosoma mansoni-infection. Acta Parasitologica 2021; 66(1): 136 doi: 10.1007/s11686-020-00267-2
|
| 37 |
Nwe Ni Than, Claire L. Tomlinson, Debashis Haldar, Andrew L. King, David Moore, Philip N. Newsome. Clinical effectiveness of cell therapies in patients with chronic liver disease and acute-on-chronic liver failure: a systematic review protocol. Systematic Reviews 2016; 5(1) doi: 10.1186/s13643-016-0277-6
|
| 38 |
Shuji Terai, Atsunori Tsuchiya. Status of and candidates for cell therapy in liver cirrhosis: overcoming the “point of no return” in advanced liver cirrhosis. Journal of Gastroenterology 2017; 52(2): 129 doi: 10.1007/s00535-016-1258-1
|
| 39 |
Philip Noel Newsome, Richard Fox, Andrew L King, Darren Barton, Nwe-Ni Than, Joanna Moore, Christopher Corbett, Sarah Townsend, James Thomas, Kathy Guo, Diana Hull, Heather A Beard, Jacqui Thompson, Anne Atkinson, Carol Bienek, Neil McGowan, Neil Guha, John Campbell, Dan Hollyman, Deborah Stocken, Christina Yap, Stuart John Forbes. Granulocyte colony-stimulating factor and autologous CD133-positive stem-cell therapy in liver cirrhosis (REALISTIC): an open-label, randomised, controlled phase 2 trial. The Lancet Gastroenterology & Hepatology 2018; 3(1): 25 doi: 10.1016/S2468-1253(17)30326-6
|
| 40 |
Hosny Salama, Abdel-Rahamn N Zekri, Rasha Ahmed, Iman Medhat, El Sayed Abdallah, Tarneem Darwish, Ola S Ahmed, Abeer Bahnassy. Assessment of health-related quality of life in patients receiving stem cell therapy for end-stage liver disease: an Egyptian study. Stem Cell Research & Therapy 2012; 3(6) doi: 10.1186/scrt140
|
| 41 |
Rania Naiem Sherif, Hussein Abdellatif, Noha Hazem, Neven A. Ebrahim, Dalia Saleh, Gamal Shiha, Huda Eltahry, Kamal G. Botros, Omar M. Gabr. Effect of human umbilical cord blood derived CD34 + hematopoietic stem cell on the expression of Wnt4 and P53 genes in a rat model of hepatocellular carcinoma. Tissue and Cell 2018; 50: 125 doi: 10.1016/j.tice.2018.01.002
|
| 42 |
Yu-Ming Wang, Ke Li, Xiao-Guang Dou, Han Bai, Xi-Ping Zhao, Xiong Ma, Lan-Juan Li, Zhi-Shui Chen, Yuan-Cheng Huang. Acute Exacerbation of Chronic Hepatitis B. 2019; : 273 doi: 10.1007/978-94-024-1603-9_4
|
| 43 |
Jeanne AdiwinataPawitan. Exploring the Most Promising Stem Cell Therapy in Liver Failure: A Systematic Review. Stem Cells International 2019; 2019: 1 doi: 10.1155/2019/2782548
|
| 44 |
Ali R. Ahmadi, George Atiee, Bart Chapman, Laurie Reynolds, John Sun, Andrew M. Cameron, Russell N. Wesson, James F. Burdick, Zhaoli Sun. A phase I, first-in-human study to evaluate the safety and tolerability, pharmacokinetics, and pharmacodynamics of MRG-001 in healthy subjects. Cell Reports Medicine 2023; 4(9): 101169 doi: 10.1016/j.xcrm.2023.101169
|
| 45 |
Maotao Huang, Zaoming Feng, Daijin Ji, Yaling Cao, Xiaoying Shi, Ping Chen, Ping Wang, Min Tang, Kai Liu. Use of a transjugular intrahepatic portosystemic shunt combined with autologous bone marrow cell infusion in patients with decompensated liver cirrhosis: an exploratory study. Cytotherapy 2014; 16(11): 1575 doi: 10.1016/j.jcyt.2014.04.007
|
| 46 |
Brian Mcneill, Aleksandra Ostojic, Katey J. Rayner, Marc Ruel, Erik J. Suuronen.
Collagen biomaterial stimulates the production of extracellular vesicles containing microRNA‐21 and enhances the proangiogenic function of CD34
+
cells
. The FASEB Journal 2019; 33(3): 4166 doi: 10.1096/fj.201801332R
|
| 47 |
Abdel-Rahman N. Zekri, Enas Reda El-Sisi, Amira Salah El-Din Youssef, Mahmoud M. Kamel, Auhood Nassar, Ola Sayed Ahmed, Mohamed El Kassas, Ahmed Barakat Barakat, Alaa Ismail Abd El-Motaleb, Abeer A. Bahnassy, Shrikant Anant. MicroRNA Signatures for circulating CD133-positive cells in hepatocellular carcinoma with HCV infection. PLOS ONE 2018; 13(3): e0193709 doi: 10.1371/journal.pone.0193709
|
| 48 |
Nicolas Lanthier, Nathalie Lin-Marq, Laura Rubbia-Brandt, Sophie Clément, Nicolas Goossens, Laurent Spahr. Autologous bone marrow-derived cell transplantation in decompensated alcoholic liver disease: what is the impact on liver histology and gene expression patterns?. Stem Cell Research & Therapy 2017; 8(1) doi: 10.1186/s13287-017-0541-2
|
| 49 |
Jeffrey M. Vainshtein, Rafi Kabarriti, Keyur J. Mehta, Jayanta Roy-Chowdhury, Chandan Guha. Bone Marrow–Derived Stromal Cell Therapy in Cirrhosis: Clinical Evidence, Cellular Mechanisms, and Implications for the Treatment of Hepatocellular Carcinoma. International Journal of Radiation Oncology*Biology*Physics 2014; 89(4): 786 doi: 10.1016/j.ijrobp.2014.02.017
|
| 50 |
Elena Konstantina Siapati, Maria G. Roubelakis, George Vassilopoulos. Liver Regeneration by Hematopoietic Stem Cells: Have We Reached the End of the Road?. Cells 2022; 11(15): 2312 doi: 10.3390/cells11152312
|
| 51 |
Valeria Iansante, Anil Chandrashekran, Anil Dhawan. Cell-based liver therapies: past, present and future. Philosophical Transactions of the Royal Society B: Biological Sciences 2018; 373(1750): 20170229 doi: 10.1098/rstb.2017.0229
|
| 52 |
Prasoon Pankaj, Qi Zhang, Xue-Li Bai, Ting-Bo Liang. Autologous bone marrow transplantation in decompensated liver: Systematic review and meta-analysis. World Journal of Gastroenterology 2015; 21(28): 8697-8710 doi: 10.3748/wjg.v21.i28.8697
|
| 53 |
Lina Cui, Yongquan Shi, Ying Han, Daiming Fan. Immunological basis of stem cell therapy in liver diseases. Expert Review of Clinical Immunology 2014; 10(9): 1185 doi: 10.1586/1744666X.2014.930665
|
| 54 |
Magda M. El-Mahdi, Wafaa A. Mansour, Olfat Hammam, Noha A. Mehana, Taghreed M. Hussein. Ameliorative Effect of Bone Marrow-Derived Stem Cells on Injured Liver of Mice Infected with Schistosoma mansoni. The Korean Journal of Parasitology 2014; 52(2): 151 doi: 10.3347/kjp.2014.52.2.151
|
| 55 |
Xiang-Rui Ma, Ya-Ling Tang, Ming Xuan, Zheng Chang, Xiao-Yi Wang, Xin-Hua Liang. Transplantation of Autologous Mesenchymal Stem Cells for End-Stage Liver Cirrhosis: A Meta-Analysis Based on Seven Controlled Trials. Gastroenterology Research and Practice 2015; 2015: 1 doi: 10.1155/2015/908275
|
| 56 |
Xiaopu Sang, Fenfang Wu, Di Wu, Shan Lin, Jingyi Li, Nan Zhao, Xiaoni Chen, Anlong Xu. Human Hepatic Cancer Stem Cells (HCSCs) Markers Correlated With Immune Infiltrates Reveal Prognostic Significance of Hepatocellular Carcinoma. Frontiers in Genetics 2020; 11 doi: 10.3389/fgene.2020.00112
|
| 57 |
Dina M. Abou Rayia, Dalia S. Ashour, Hend S. Abo Safia, Muhammad T. Abdel Ghafar, Rania S. Amer, Abeer E. Saad. Human umbilical cord blood mesenchymal stem cells as a potential therapy for schistosomal hepatic fibrosis: an experimental study. Pathogens and Global Health 2023; 117(2): 190 doi: 10.1080/20477724.2022.2064795
|
| 58 |
Tae Il Kim. Clinical Trials with Stem Cells in Digestive Diseases and Future Perspectives. The Korean Journal of Gastroenterology 2011; 58(3): 139 doi: 10.4166/kjg.2011.58.3.139
|
| 59 |
Nipun Verma, Amritjyot Kaur, Ratiram Sharma, Ashish Bhalla, Navneet Sharma, Arka De, Virendra Singh. Outcomes after multiple courses of granulocyte colony‐stimulating factor and growth hormone in decompensated cirrhosis: A randomized trial. Hepatology 2018; 68(4): 1559 doi: 10.1002/hep.29763
|
| 60 |
Fan Chen. Therapeutic Strategies of Stem Cell Transplantation for Liver Cirrhosis. Yangtze Medicine 2017; 1(02): 77 doi: 10.4236/ym.2017.12008
|
| 61 |
Ensieh Zahmatkesh, Niloofar Khoshdel Rad, Nikoo Hossein-Khannazer, Mehdi Mohamadnejad, Roberto Gramignoli, Mustapha Najimi, Reza Malekzadeh, Moustapha Hassan, Massoud Vosough. Cell and cell-derivative-based therapy for liver diseases: current approaches and future promises. Expert Review of Gastroenterology & Hepatology 2023; 17(3): 237 doi: 10.1080/17474124.2023.2172398
|